Overview

Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of the study "Fluorescence-guided resection of malignant gliomas with 5-Aminolevulinic acid (5-ALA) vs. conventional resection" is to determine how accurately contrast agent-accumulating tumour can be removed by primary surgery and to assess the clinical usefulness of this method.
Phase:
Phase 3
Details
Lead Sponsor:
medac GmbH
Treatments:
Aminolevulinic Acid